Effect of thrombin fragment (TP508) on myocardial ischemia-reperfusion injury in hypercholesterolemic pigs
Open Access
- 1 June 2009
- journal article
- research article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 106 (6) , 1993-2001
Abstract
Myocardial ischemia-reperfusion (IR) injury occurs frequently in the setting of hypercholesterolemia. We investigated the potential efficacy of a novel thrombin fragment (TP508) on IR injury in a hypercholesterolemic porcine model. Twenty-one hypercholesterolemic male Yucatan pigs underwent 60 min of mid-left anterior descending coronary artery occlusion followed by 120 min of reperfusion. Pigs received either placebo (control, n = 7) or TP508 in two doses (TP508 low dose, n = 7, as bolus of 0.5 mg/kg 50 min into ischemia and an infusion of 1.25 mg·kg−1·h−1 during reperfusion period or TP508 high dose, n = 7, a double dose of TP508 low-dose group). Myocardial function was monitored throughout the experiment. The area at risk and myocardial necrosis were determined by Monastryl blue/triphenyl tetrazolium chloride staining. Apoptosis in the ischemic territory was assessed. Coronary microvascular reactivity to endothelium-dependent and -independent factors was measured. Myocardial necrosis was lower in both TP508-treated groups vs. control ( P < 0.05). Regional left ventricular function was improved only in the TP508 high-dose group ( P < 0.05). Endothelium-dependent coronary microvascular reactivity was greater in both TP508-treated groups ( P < 0.05) vs. control. The expression of proteins favoring cell survival, 90-kDa heat shock protein and phospho-Bad (Ser112) was higher in the TP508 high-dose group ( P < 0.05). The expression of the cell death signaling proteins, cleaved caspase-3 ( P < 0.05), apoptosis-inducing factor ( P < 0.05), and poly-ADP ribose polymerase ( P = 0.07) was lower in the TP508 low-dose group vs. TP508 high-dose and control. The terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling positive cell count was lower in both TP508 groups compared with the control ( P < 0.05). This study demonstrates that, in hypercholesterolemic pigs, TP508 decreases myocardial necrosis and apoptosis after IR. Thus TP508 may offer a novel approach in protecting the myocardium from IR injury.Keywords
This publication has 43 references indexed in Scilit:
- Effect of Hypercholesterolemia on Myocardial Necrosis and Apoptosis in the Setting of Ischemia-ReperfusionCirculation, 2009
- LKB1 Is Necessary for Akt-Mediated Phosphorylation of Proapoptotic ProteinsCancer Research, 2008
- TP508 (Chrysalin®) Reverses Endothelial Dysfunction and Increases Perfusion and Myocardial Function in Hearts With Chronic IschemiaJournal of Cardiovascular Pharmacology and Therapeutics, 2008
- The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia–reperfusion injury☆☆☆European Journal of Cardio-Thoracic Surgery, 2008
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007
- Thrombin peptide (TP508) promotes fracture repair by up-regulating inflammatory mediators, early growth factors, and increasing angiogenesisJournal of Orthopaedic Research, 2005
- Dysfunction of Endothelial Nitric Oxide Synthase and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Pharmacological Prevention of Reperfusion Injury in Acute Myocardial InfarctionAmerican Journal of Cardiovascular Drugs, 2004
- On the mode of action of thrombin-induced angiogenesis: thrombin peptide, TP508, mediates effects in endothelial cells via αvβ3 integrinThrombosis and Haemostasis, 2004
- Role of Poly(ADP-ribose) Polymerase (PARP) Cleavage in ApoptosisJournal of Biological Chemistry, 1999